Nanocopoeia Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NANOCOPOEIA, and when can generic versions of NANOCOPOEIA drugs launch?
NANOCOPOEIA has one approved drug.
There are three US patents protecting NANOCOPOEIA drugs.
There are six patent family members on NANOCOPOEIA drugs in six countries and eleven supplementary protection certificates in ten countries.
Drugs and US Patents for Nanocopoeia
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nanocopoeia | PHYRAGO | dasatinib | TABLET;ORAL | 216099-004 | Dec 5, 2023 | RX | Yes | No | 11,324,745 | ⤷ Sign Up | ⤷ Sign Up | ||||
Nanocopoeia | PHYRAGO | dasatinib | TABLET;ORAL | 216099-006 | Dec 5, 2023 | RX | Yes | No | 11,324,745 | ⤷ Sign Up | ⤷ Sign Up | ||||
Nanocopoeia | PHYRAGO | dasatinib | TABLET;ORAL | 216099-005 | Dec 5, 2023 | RX | Yes | Yes | 11,298,356 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Nanocopoeia | PHYRAGO | dasatinib | TABLET;ORAL | 216099-002 | Dec 5, 2023 | RX | Yes | No | 11,202,778 | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Nanocopoeia Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 4093379 | ⤷ Sign Up |
Canada | 3168667 | ⤷ Sign Up |
Israel | 294928 | ⤷ Sign Up |
Japan | 2023513444 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Nanocopoeia Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1169038 | 6/2013 | Austria | ⤷ Sign Up | PRODUCT NAME: DASATINIB UND PHARMAZEUTISCH VERTRAEGLICHE SALZE DAVON; REGISTRATION NO/DATE: EU/1/06/363/001-015 20061120 |
1169038 | 132013902119320 | Italy | ⤷ Sign Up | PRODUCT NAME: DASATINIB E I SUOI SALI FARMACEUTICAMENTE ACCETTABILI(SPRYCEL); AUTHORISATION NUMBER(S) AND DATE(S): DA EU/1/06/363/001 A EU/I/06/363/015, 20061120 |
1169038 | CA 2013 00006 | Denmark | ⤷ Sign Up | PRODUCT NAME: DASATINIB OG FARMACEUTISK ACCEPTABLE SALTE DERAF, HERUNDER MONOHYDRATET; REG. NO/DATE: EU/1/06/363/001-015 20061122 |
1169038 | C300567 | Netherlands | ⤷ Sign Up | PRODUCT NAME: DASATINIB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/06/363/001 .... 009 20061120 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.